FIELD: pharmacology.
SUBSTANCE: invention relates to medicine and is a method for production of rifampicine polymeric complexes with reduced toxicity and high antituberculosis activity by rifampicine complexing with anionic polyelectrolyte in its aqueous solution. Poly-2-acrylamido-2-methylpropanesulphonic acid with a molecular weight of 20,000-40,000 is used as an anionic polyelectrolyte, complexation is performed at a weight ratio of polymer:antibiotic equal to 1.9-4.0.
EFFECT: decreased rifampicin toxicity while preserving high level of anti-TB activity.
1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF GENTAMYCIN MODIFICATION WITH VINYLPIRROLIDONE COPOLYMER WITH ACRYOLINE DIAGETALUM | 2017 |
|
RU2659032C1 |
WATER-SOLUBLE POLYMERIC COMPLEXES OF ARBIDOL | 2008 |
|
RU2394618C2 |
POLYDIALLYLAMMONIUM SALTS AS MYCOBACTERICIDAL AND TUBERCULOCIDAL DISINFECTANT | 2009 |
|
RU2415679C1 |
WATER-SOLUBLE POLYMER COMPLEXES OF AMINOGLYCOSIDE ANTIBIOTICS | 2006 |
|
RU2335510C2 |
DRUG FOR TREATING AND PREVENTING COMPLICATIONS ASSOCIATED WITH CHEMOTHERAPY AND X-RAY THERAPY, AS WELL AS CONDITIONS ASSOCIATED WITH HIGH PERMEABILITY OF THE INTESTINE | 2018 |
|
RU2692469C1 |
PHARMACOLOGICAL AGENT POSSESSING ANTITUBERCULOSIS ACTIVITY | 2011 |
|
RU2469711C1 |
TUBERCULOUS AGENT AS SOLUTION FOR INJECTION | 2007 |
|
RU2358742C2 |
METHOD FOR PRODUCING POLYMERIC COMPLEX | 2010 |
|
RU2435611C1 |
BIOLOGICALLY ACTIVE POLYMERIC MEDICAL COMPOSITION (VERSION) | 2010 |
|
RU2447902C2 |
METHOD OF PRODUCING WATER-SOLUBLE COPOLYMERS OF N-VINYL AMIDES CONTAINING ALDEHYDE GROUPS | 2015 |
|
RU2594253C1 |
Authors
Dates
2017-06-29—Published
2016-08-04—Filed